<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37215068</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-7156</ISSN><JournalIssue CitedMedium="Internet"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of immunology research</Title><ISOAbbreviation>J Immunol Res</ISOAbbreviation></Journal><ArticleTitle>Exosome Derived from Human Umbilical Cord Mesenchymal Cell Exerts Immunomodulatory Effects on B Cells from SLE Patients.</ArticleTitle><Pagination><StartPage>3177584</StartPage><MedlinePgn>3177584</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3177584</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2023/3177584</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Excessive proliferation and activation of B cells, resulting in the production of various autoantibodies, is a crucial link and significant feature of the pathogenesis of systemic lupus erythematosus (SLE), as well as the pathological basis of systemic multiorgan damage. However, whether exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs-Exo) are involved in the immune regulation of SLE has not been clarified.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Therefore, our study aimed to investigate the efficacy of hucMSCs-Exo for treating SLE.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">hucMSCs-Exo and peripheral blood mononuclear cells (PBMCs) of SLE patients were cocultured <i>in vitro</i>, and B cell apoptosis, activation, proliferation, and inflammation levels were detected by flow cytometry. Subsequently, the expression level of miR-155 in B lymphocytes of SLE patients was detected by qRT-PCR, and the target gene relationship between miR-155 and SHIP-1 was found through bioinformatics and dual luciferase activity experiments, which verified the inhibition of miR-155 in B lymphocytes of SLE patients to regulate immunity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We found that hucMSCs-Exo promoted B cell apoptosis, prevented B cell overactivation, and reduced inflammation. MicroRNA-155 (miR-155) has a powerful regulatory function in B cells. It was demonstrated that hucMSCs-Exo acts synergistically with miR-155 inhibitors to target SHIP-1 to B cells more effectively than exosomes alone.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our results provide insight into how hucMSCs-Exo regulates autoimmunity in patients with lupus and suggest targeting miR-155 for autoimmunity while protecting immunity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ying Zhao et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9146-3662</Identifier><AffiliationInfo><Affiliation>School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Basic Medical Laboratory, General Hospital of the Central Theater Command, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Central Nervous System Tumor and Intervention, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Song</LastName><ForeName>Wenbin</ForeName><Initials>W</Initials><Identifier Source="ORCID">0009-0002-9682-0128</Identifier><AffiliationInfo><Affiliation>People's Hospital of Xinyang, Xinyang 464000, Hennan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zilin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7927-1844</Identifier><AffiliationInfo><Affiliation>Basic Medical Laboratory, General Hospital of the Central Theater Command, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Central Nervous System Tumor and Intervention, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Min</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8998-5667</Identifier><AffiliationInfo><Affiliation>Basic Medical Laboratory, General Hospital of the Central Theater Command, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Central Nervous System Tumor and Intervention, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Gang</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0439-0718</Identifier><AffiliationInfo><Affiliation>Basic Medical Laboratory, General Hospital of the Central Theater Command, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Central Nervous System Tumor and Intervention, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liping</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0000-5037-4594</Identifier><AffiliationInfo><Affiliation>Basic Medical Laboratory, General Hospital of the Central Theater Command, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Central Nervous System Tumor and Intervention, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yueping</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9826-612X</Identifier><AffiliationInfo><Affiliation>Basic Medical Laboratory, General Hospital of the Central Theater Command, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Central Nervous System Tumor and Intervention, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diao</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2209-6061</Identifier><AffiliationInfo><Affiliation>Basic Medical Laboratory, General Hospital of the Central Theater Command, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Central Nervous System Tumor and Intervention, Wuhan 430070, Hubei Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>J Immunol Res</MedlineTA><NlmUniqueID>101627166</NlmUniqueID><ISSNLinking>2314-7156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.3.86</RegistryNumber><NameOfSubstance UI="D000072183">Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C524942">MIRN155 microRNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072183" MajorTopicYN="N">Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014470" MajorTopicYN="N">Umbilical Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>12</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37215068</ArticleId><ArticleId IdType="pmc">PMC10198761</ArticleId><ArticleId IdType="doi">10.1155/2023/3177584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Costenbader K. H., Feskanich D., Stampfer M. J., Karlson E. W. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis &amp; Rheumatism . 2007;56(4):1251&#x2013;1262. doi: 10.1002/art.22510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22510</ArticleId><ArticleId IdType="pubmed">17393454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciascia S., Radin M., Roccatello D., Sanna G., Bertolaccini M. L. Recent advances in the management of systemic lupus erythematosus [version 1; peer review: 2 approved] F1000Research . 2018;7 doi: 10.12688/f1000research.13941.1.970</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.13941.1</ArticleId><ArticleId IdType="pmc">PMC6039948</ArticleId><ArticleId IdType="pubmed">30026918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Q., Wu M., Zhong L., et al. Development of a xeno-free feeder-layer system from human umbilical cord mesenchymal stem cells for prolonged expansion of human induced pluripotent stem cells in culture. PLOS ONE . 2016;11(2) doi: 10.1371/journal.pone.0149023.e149023</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0149023</ArticleId><ArticleId IdType="pmc">PMC4755601</ArticleId><ArticleId IdType="pubmed">26882313</ArticleId></ArticleIdList></Reference><Reference><Citation>Can A., Celikkan F. T., Cinar O. Umbilical cord mesenchymal stromal cell transplantations: a systemic analysis of clinical trials. Cytotherapy . 2017;19(12):1351&#x2013;1382. doi: 10.1016/j.jcyt.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2017.08.004</ArticleId><ArticleId IdType="pubmed">28964742</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi P., Halabian R., Fooladi A. A. I. A revealing review of mesenchymal stem cells therapy, clinical perspectives and modification strategies. Stem Cell Investigation . 2019;6 doi: 10.21037/sci.2019.08.11.34</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/sci.2019.08.11</ArticleId><ArticleId IdType="pmc">PMC6789202</ArticleId><ArticleId IdType="pubmed">31620481</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma O. K.-F., Chan K. H. Immunomodulation by mesenchymal stem cells: interplay between mesenchymal stem cells and regulatory lymphocytes. World Journal of Stem Cells . 2016;8(9):268&#x2013;278. doi: 10.4252/wjsc.v8.i9.268.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v8.i9.268</ArticleId><ArticleId IdType="pmc">PMC5031888</ArticleId><ArticleId IdType="pubmed">27679683</ArticleId></ArticleIdList></Reference><Reference><Citation>Crigna A. T., Daniele C., Gamez C., et al. Stem/stromal cells for treatment of kidney injuries with focus on preclinical models. Frontiers in Medicine . 2018;5 doi: 10.3389/fmed.2018.00179.179</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2018.00179</ArticleId><ArticleId IdType="pmc">PMC6013716</ArticleId><ArticleId IdType="pubmed">29963554</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.-Y., Rao S.-S., Ren L., et al. Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics . 2018;8(6):1607&#x2013;1623. doi: 10.7150/thno.22958.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.22958</ArticleId><ArticleId IdType="pmc">PMC5858170</ArticleId><ArticleId IdType="pubmed">29556344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ti D., Hao H., Tong C., et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. Journal of Translational Medicine . 2015;13 doi: 10.1186/s12967-015-0642-6.308</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-015-0642-6</ArticleId><ArticleId IdType="pmc">PMC4575470</ArticleId><ArticleId IdType="pubmed">26386558</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee N., Talcott S., Safe S., Mertens-Talcott S. U. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Research and Treatment . 2012;136:21&#x2013;34. doi: 10.1007/s10549-012-2224-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-012-2224-0</ArticleId><ArticleId IdType="pmc">PMC3488590</ArticleId><ArticleId IdType="pubmed">22941571</ArticleId></ArticleIdList></Reference><Reference><Citation>Calame K. MicroRNA-155 function in B cells. Immunity . 2007;27(6):825&#x2013;827. doi: 10.1016/j.immuni.2007.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.11.010</ArticleId><ArticleId IdType="pubmed">18093533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashi E., Wang Y. H., Diamond B. The role of B cells in lupus pathogenesis. The International Journal of Biochemistry &amp; Cell Biology . 2010;42(4):543&#x2013;550. doi: 10.1016/j.biocel.2009.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2009.10.011</ArticleId><ArticleId IdType="pmc">PMC2835836</ArticleId><ArticleId IdType="pubmed">19850148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis &amp; Rheumatism . 1997;40(9) doi: 10.1002/(ISSN)1529-0131.1725</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(ISSN)1529-0131</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Zhang J., Liu Z., Gong Y., Zheng Z. Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial&#x2013;mesenchymal transition by targeting HOXC6. Stem Cell Research &amp; Therapy . 2021;12 doi: 10.1186/s13287-020-02064-0.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-020-02064-0</ArticleId><ArticleId IdType="pmc">PMC7792361</ArticleId><ArticleId IdType="pubmed">33413548</ArticleId></ArticleIdList></Reference><Reference><Citation>Isnardi I., Bruhns P., Bismuth G., Fridman W. H., Da&#xeb;ron M. The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human Fc&#x3b3;RIIB and is mandatory for negative regulation of B cell activation. Immunology Letters . 2006;104(1-2):156&#x2013;165. doi: 10.1016/j.imlet.2005.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2005.11.027</ArticleId><ArticleId IdType="pubmed">16406061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cond&#xe9; C., Gloire G., Piette J. Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer. Biochemical Pharmacology . 2011;82(10):1320&#x2013;1334. doi: 10.1016/j.bcp.2011.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.05.031</ArticleId><ArticleId IdType="pubmed">21672530</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill S. K., Getahun A., Gauld S. B., et al. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity . 2011;35(5):746&#x2013;756. doi: 10.1016/j.immuni.2011.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.10.011</ArticleId><ArticleId IdType="pmc">PMC3232011</ArticleId><ArticleId IdType="pubmed">22078222</ArticleId></ArticleIdList></Reference><Reference><Citation>Thai T.-H., Patterson H. C., Pham D.-H., Kis-Toth K., Kaminski D. A., Tsokos G. C. Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Faslpr mouse. PNAS . 2013;110(50):20194&#x2013;20199. doi: 10.1073/pnas.1317632110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1317632110</ArticleId><ArticleId IdType="pmc">PMC3864325</ArticleId><ArticleId IdType="pubmed">24282294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang K., Yang J., Guo S., Zhao G., Wu H., Deng G. Peripheral circulating exosome-mediated delivery of miR-155 as a novel mechanism for acute lung inflammation. Molecular Therapy . 2019;27(10):1758&#x2013;1771. doi: 10.1016/j.ymthe.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2019.07.003</ArticleId><ArticleId IdType="pmc">PMC6822235</ArticleId><ArticleId IdType="pubmed">31405809</ArticleId></ArticleIdList></Reference><Reference><Citation>Riazifar M., Rezza Mohammadi M., Pone E. J., et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano . 2019;13(6):6670&#x2013;6688. doi: 10.1021/acsnano.9b01004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.9b01004</ArticleId><ArticleId IdType="pmc">PMC6880946</ArticleId><ArticleId IdType="pubmed">31117376</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Tam L.-S., Li E. K.-M., et al. Serum and urinary cell&#x2212;free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. The Journal of Rheumatology . 2010;37(12):2516&#x2013;2522. doi: 10.3899/jrheum.100308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.100308</ArticleId><ArticleId IdType="pubmed">20952466</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R., Zhang Y., Khan D., et al. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLOS ONE . 2010;5(12) doi: 10.1371/journal.pone.0014302.e14302</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014302</ArticleId><ArticleId IdType="pmc">PMC3000827</ArticleId><ArticleId IdType="pubmed">21170274</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap D., Lai K. Pathogenesis of renal disease in systemic lupus erythematosus&#x2014;the role of autoantibodies and lymphocytes subset abnormalities. International Journal of Molecular Sciences . 2015;16(4):7917&#x2013;7931. doi: 10.3390/ijms16047917.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms16047917</ArticleId><ArticleId IdType="pmc">PMC4425058</ArticleId><ArticleId IdType="pubmed">25860947</ArticleId></ArticleIdList></Reference><Reference><Citation>Foote J. B., Mahmoud T. I., Vale A. M., Kearney J. F. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells. The Journal of Immunology . 2012;188(1):57&#x2013;67. doi: 10.4049/jimmunol.1100783.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100783</ArticleId><ArticleId IdType="pmc">PMC3244511</ArticleId><ArticleId IdType="pubmed">22116821</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>